Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients-Reference-Cited by-同舟云学术

Evidence-based recommendations for induction and maintenance treatment of newly diagnosed transplant-ineligible multiple myeloma patients

Published:2022-08 Issue: Volume:176 Page:103744
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Rafae Abdul,Ehsan Hamid,Wahab Ahsan,Khan Sana Irfan,Khan Israr,Ashraf Sara,Ali Sundas,Khalid Farhan,Neupane Karun,Valent Jason,Khouri Jack,Samaras Christy,Mazzoni Sandra,Anwer Faiz

Funder

Medical University of South Carolina

Michigan State University

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference37 articles.

1. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma;Benboubker;N. Engl. J. Med.,2014

2. All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma;Dimopoulos;Eur. J. Cancer,2019

3. Ixazomib as postinduction maintenance for patients with newly diagnosed multiple myeloma not undergoing autologous stem cell transplantation: the phase III TOURMALINE-MM4 Trial;Dimopoulos;J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol.,2020

4. Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)

5. Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma;Facon;Blood,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspectives on the Treatment of Multiple Myeloma;The Oncologist;2023-11-23

2. Cell division cycle 37 change after bortezomib-based induction therapy helps to predict clinical response and prognosis in multiple myeloma patients;Hematology;2023-07-06

3. Multiple myeloma patients undergoing chemotherapy: Which symptom clusters impact quality of life?;Journal of Clinical Nursing;2023-06-12

4. The core symptom in multiple myeloma patients undergoing chemotherapy: a network analysis;Supportive Care in Cancer;2023-04-25